Company news
Novaccess Global Inc. news in 2023
Novaccess Global Inc.'s news releases, calls and decks from 2023, newest first.
NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board
November 9, 2023
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
July 26, 2023
NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day
July 12, 2023
NovAccess Global Partners with CKN Ventures to Expand its New AI-driven Precision Medicine Division
June 15, 2023
NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies
May 31, 2023
NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements
May 10, 2023
Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award
March 14, 2023
NovAccess Global to Present at World Orphan Drug Congress
February 15, 2023
NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress
February 2, 2023
NovAccess Global Announces Fireside Chat with Dr. Christopher Wheeler, the Company’s Lead Scientist and President of its StemVax Therapeutics Division
January 4, 2023
Decks in 2023
- Virtual Investor Summit December 2023
Conference · 21 slides · December 2023
- World Orphan Drug Congress USA 2023
Conference · 19 slides · May 24, 2023
- Investor Presentation (February 2023)
Investor deck · 18 slides · February 2023